Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - Esperion Therapeutics, Inc. | a2230972zex-31_1.htm |
EX-23.1 - EX-23.1 - Esperion Therapeutics, Inc. | a2230972zex-23_1.htm |
10-K - 10-K - Esperion Therapeutics, Inc. | a2230972z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Esperion Therapeutics, Inc., a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:
The Annual Report for the year ended December 31, 2016 (the "Form 10-K") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: February 22, 2017 | /s/ TIM M. MAYLEBEN Tim M. Mayleben President and Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) |
CERTIFICATIONS UNDER SECTION 906